Hochschulschrift
Evaluation einer Definition und der Prävalenz des hyperdynamischen Kreislaufes bei Patienten mit Leberzirrhose und Aszites
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
31 cm
- Extent
-
VI, 72 Blätter
- Language
-
Deutsch
- Notes
-
Illustrationen, Diagramme
Martin-Luther-Universität Halle-Wittenberg, Dissertation, 2022
- Keyword
-
Hämodynamik
Pathophysiologie
Kardiovaskuläre Krankheit
- Event
-
Veröffentlichung
- (where)
-
Halle, Wittenberg
- (when)
-
[2022]
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 11:40 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- [2022]
Other Objects (12)
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Klinisches Vorgehen bei Leberabszessen
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
Chirurgische Therapiemöglichkeiten bei leberzirrhose-bedingten Aszites
Blutgerinnungsfaktoren im Aszites bei dekompensierter Leberzirrhose
Aldosteron und Renin bei Leberzirrhose mit Aszites
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC : : an international observational study
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Klinisches Vorgehen bei Leberabszessen
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
Chirurgische Therapiemöglichkeiten bei leberzirrhose-bedingten Aszites
Blutgerinnungsfaktoren im Aszites bei dekompensierter Leberzirrhose
Aldosteron und Renin bei Leberzirrhose mit Aszites
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC : : an international observational study
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Klinisches Vorgehen bei Leberabszessen
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
Chirurgische Therapiemöglichkeiten bei leberzirrhose-bedingten Aszites
Blutgerinnungsfaktoren im Aszites bei dekompensierter Leberzirrhose
Aldosteron und Renin bei Leberzirrhose mit Aszites